Zeo ScientifiX (ZEOX) Research & Development (2025 - 2026)
Zeo ScientifiX (ZEOX) posted Research & Development of $31000.0 for Q2 2026, up 63.16% on a QoQ basis from $19000.0 in Q1 2026, and down 26.19% year-over-year from $42000.0 in Q2 2025.
Powered by 
Analysis
Zeo ScientifiX (ZEOX) Research & Development (2025 - 2026) Analysis & Trends
Zeo ScientifiX has reported Research & Development for 2 years, with the latest figure at $31000.0 in Q2 2026.
- On a quarterly basis, Research & Development fell 26.19% year-over-year to $31000.0 in Q2 2026; TTM through Apr 2026 was $98000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $100000.0, down 39.02% from the prior year.
- Research & Development was $31000.0 for Q2 2026 at Zeo ScientifiX, up from $19000.0 in the prior quarter.
- The five-year high for Research & Development was $42000.0 in Q2 2025, with the low at $6000.0 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 14.52 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | 67.15 Mn |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 58.85 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | -96.00 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 33.96 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | 95.10 Mn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 7.28 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | 91.26 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 7.49 Mn |
| 10 | Zeo ScientifiX | 8.53 Mn | 6.69 Mn | 2.06 Mn | 31,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 31,000.00 |
| Jan 31, 2026 | 19,000.00 |
| Apr 30, 2025 | 42,000.00 |
| Jan 31, 2025 | 6,000.00 |